Does ROSIGLITAZONE Cause Hyperlipidaemia? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Hyperlipidaemia have been filed in association with ROSIGLITAZONE. This represents 0.1% of all adverse event reports for ROSIGLITAZONE.
66
Reports of Hyperlipidaemia with ROSIGLITAZONE
0.1%
of all ROSIGLITAZONE reports
1
Deaths
18
Hospitalizations
How Dangerous Is Hyperlipidaemia From ROSIGLITAZONE?
Of the 66 reports, 1 (1.5%) resulted in death, 18 (27.3%) required hospitalization.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does ROSIGLITAZONE Cause?
Myocardial infarction (17,018)
Cardiac failure congestive (15,085)
Cerebrovascular accident (7,899)
Coronary artery disease (4,982)
Acute myocardial infarction (2,437)
Cardiac disorder (1,732)
Coronary arterial stent insertion (1,698)
Coronary artery bypass (1,181)
Chest pain (990)
Myocardial ischaemia (970)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which ROSIGLITAZONE Alternatives Have Lower Hyperlipidaemia Risk?
ROSIGLITAZONE vs ROSUVASTATIN
ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN
ROSIGLITAZONE vs ROTIGOTINE
ROSIGLITAZONE vs ROXADUSTAT
ROSIGLITAZONE vs ROXICODONE